Drugs & Targets CHMP issues positive opinion Keytruda + chemo as first-line treatment for metastatic biliary tract cancer November 17, 2023Vol.49 No.43
Drugs & Targets Legend Biotech, Novartis partner to advance SCLC research November 17, 2023Vol.49 No.43
Drugs & Targets FDA approves Fruzaqla for previously treated metastatic CRC November 10, 2023Vol.49 No.42
Drugs & Targets Cancer Research UK, KWF Dutch Cancer Society enter partnership to bring drugs into clinical development November 10, 2023Vol.49 No.42
Drugs & Targets AnHeart enters into exclusive license agreement with Nippon Kayaku to market and distribute taletrectinib in Japan November 03, 2023Vol.49 No.41
Drugs & Targets FDA approves neoadjuvant/ adjuvant Keytruda for resectable NSCLC October 20, 2023Vol.49 No.39
